Immunic
Price & Volume
Stats
See more52W Range | $5.06-$17.43 |
Market Cap | $108.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.83 |
News
See moreYahoo Finance • 2 months ago
Immunic advances MS drug toward key Phase 3 data, expects results by year-end
Yahoo Finance • 5 months ago
Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials
Yahoo Finance • 5 months ago
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
Yahoo Finance • 5 months ago
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
About
CEO | Mr. Erik Lundgren |
Address | 1200 Avenue of the Americas, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |